Vanessa Fernandes Rodrigues

Dr. Vanessa Fernandes Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Life Sciences
Verified
Journal Article
Closed access
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
JEJefferson Elias-Oliveira
Jefferson Elias-Oliveira
ÍPÍtalo Sousa Pereira
Ítalo Sousa Pereira
JPJéssica Assis Pereira
Jéssica Assis Pereira
SBSara Cândida Barbosa
Sara Cândida Barbosa
DCDaniela Carlos
Daniela Carlos

9 September 2015 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
MRMichelle Carvalho de Rezende
Michelle Carvalho de Rezende
EAEmília Souza Araújo
Emília Souza Araújo
JMJoão Marcelo Peixoto Moreira
João Marcelo Peixoto Moreira
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
JRJailza Lima Rodrigues
Jailza Lima Rodrigues
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)

1 March 2020 in Cytokine
Verified
Journal Article
Closed access
MRMichelle Carvalho de Rezende
Michelle Carvalho de Rezende
JMJoão Marcelo Peixoto Moreira
João Marcelo Peixoto Moreira
LFLaura Liana Maggi Fernandes
Laura Liana Maggi Fernandes
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)

1 September 2021 in Immunobiology
Verified
Journal Article
Closed access
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
MRMichelle Carvalho de Rezende
Michelle Carvalho de Rezende
LMLaura Maggi
Laura Maggi
JSJeferson Kelvin Alves Oliveira Silva
Jeferson Kelvin Alves Oliveira Silva
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)

18 January 2024 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
JRJoão Gustavo M. Rodrigues
João Gustavo M. Rodrigues
GMGuilherme Silva Miranda
Guilherme Silva Miranda
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
JSJeferson Kelvin Silva
Jeferson Kelvin Silva
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)

20 August 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MMMelissa Santana Gonsalez Machado
Melissa Santana Gonsalez Machado
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
SBSara Cândida Barbosa
Sara Cândida Barbosa
JOJefferson Elias Oliveira
Jefferson Elias Oliveira
ÍPÍtalo S. Pereira
Ítalo S. Pereira
DCDaniela Carlos
Daniela Carlos
Intestinal permeability and bacterial translocation are increased in obesity and metabolic syndrome (MS). ILC3 cells contribute to the integrity of intestinal epithelium by producing IL-22 via IL-1β and IL-23. This study investigates the role of IL-1R1 in inducing ILC3 cells and conferring protection during obesity and MS. For this purpose, C57BL/6 wild-type (WT) and IL-1R1-deficient mice were fed a standard diet (SD) or high-fat diet (HFD) for 16 weeks. Weight and blood glucose levels were monitored, and adipose tissue and blood samples were collected to evaluate obesity and metabolic parameters. The small intestine was collected to assess immunological and junction protein parameters through flow cytometry and RT-PCR, respectively. The intestinal permeability was analyzed using the FITC-dextran assay. The composition of the gut microbiota was also analyzed by qPCR. We found that IL-1R1 deficiency exacerbates MS in HFD-fed mice, increasing body fat and promoting glucose intolerance. A worsening of MS in IL-1R1-deficient mice was associated with a reduction in the ILC3 population in the small intestine. In addition, we found decreased IL-22 expression, increased intestinal permeability and bacterial translocation to the visceral adipose tissue of these mice compared to WT mice. Thus, the IL-1R1 receptor plays a critical role in controlling intestinal homeostasis and obesity-induced MS, possibly through the differentiation or activation of IL-22-secreting ILC3s.